It can really be stressful for parents when their children, who appear completely healthy and achieve all early growth milestones, unexpectedly start having long seizures after a fever. This could be Dravet syndrome, a rare but severe epilepsy that begins in infancy and is highly treatment-resistant.
The duration of these seizures elevates the risk of life-threatening complications, including status epilepticus. It is a genetic disorder which is often misunderstood and overlooked, but research is finally finding more profound genetic connections and new treatments.
Read on to learn more.
Dravet syndrome is a severe, rare type of genetic epilepsy that usually starts during the infant's first year of life, even among otherwise healthy children.
Usually triggered by a fever, the seizures initially experienced are prolonged and resistant to treatment. Subsequently, children have several types of seizures, with most being resistant to conventional therapies.
Aside from epilepsy, Dravet syndrome also results in developmental delays, speech and motor impairments, and other neurological disorders. It is considered developmental and epileptic encephalopathy (DEE) and was previously referred to as severe myoclonic epilepsy of infancy.
Dravet syndrome is associated with a variety of symptoms, beginning in infancy with seizures and leading to other developmental, behavioural, and neurological concerns. The symptoms can vary in severity and in combination. These include:
Other symptoms may arise during childhood, including:
Yes, Dravet syndrome is a genetic disorder, most commonly caused by a mutation in the SCN1A gene that affects how brain cells communicate with each other. Usually, the mutation occurs spontaneously and is not inherited; however, it may be passed down occasionally, either through mosaicism or autosomal dominant inheritance.
Having an SCN1A variant does not necessarily mean someone will have Dravet syndrome—some may have more benign epilepsy or no symptoms at all.
The most severe complications can be life-threatening and may involve:
As of now, there is no cure for Dravet syndrome since it is a lifelong genetic disorder and cannot be prevented. The condition itself cannot be prevented, many of its complications (e.g., injuries from falls, status epilepticus) can be prevented or mitigated through vigilant management, rescue medications, and safety precautions. However, ongoing research, including clinical trials in gene therapy, is also being conducted.
These studies pave the way for future precision medicine treatments. The care and management of Dravet syndrome aim to provide the best seizure management and quality of life, with each patient's management plan being individualised according to the patient's and family's needs.
The primary aim of treatment is to curb seizure severity and frequency, avoid complications such as status epilepticus, and enhance neurological and developmental function. Some of the key treatment methods include:
Dravet syndrome is a complicated, chronic neurological disorder based on genetic impairment. Early diagnosis and advanced treatment hold the key to optimal outcomes. As new therapies become available and genetic understanding broadens, promise indeed exists for individuals with this critical epilepsy.